20/share is lowball. Now, for Brilacidin-OM alone, or Prurisol alone -- I'd take it for that portion of the company.
Look at JAZZ, at 180 with a much less momentous pipeline that CTIX.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
-
-
-
-
-
-
-